Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Lexicon Pharmaceuticals ( (LXRX) ) has shared an update.
Lexicon Pharmaceuticals announced the appointment of Scott M. Coiante as senior vice president and chief financial officer, effective January 2, 2025. Coiante, a certified public accountant with extensive experience in senior financial roles at various biotechnology and pharmaceutical companies, will receive a base salary of $450,000 and be eligible for performance-based bonuses and stock options as part of his compensation package.
More about Lexicon Pharmaceuticals
Average Trading Volume: 4,264,514
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $267M
For detailed information about LXRX stock, go to TipRanks’ Stock Analysis page.
